Print

Brainsway (BRSYF.PK) Announces Breakthrough Results in Clinical Trials in Parkinson's, Migraine and More  
11/14/2012 7:38:59 AM

JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to Brainsway's (TASE:BRIN) announcement regarding the association between Brainsway and Advanced Technologies Innovation Distribution SRL ("ATID") for the marketing and sales promotion of Brainsway's Deep TMS devices in Italy, in the context of which ATID has been conducting - among its other activities - clinical trials in the San Raffaele medical center in Milan, Italy, the Company is pleased to announce the following clinical trial results: